Sildenafil citrate augments myocardial protection in heart transplantation

Transplantation

Volumn 89, Issue 2, 2010, Pages 169-177

  Botha, Phil ^a,b   MacGowan, Guy A ^b,c   Dark, John H ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cardiac transplantation; Ischemia reperfusion injury; Myocardial protection; Phosphodiesterase inhibitors; Sildenafil citrate

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; PROTEIN KINASE C DELTA; SILDENAFIL; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARDIOPLEGIA; CELL DAMAGE; CONTROLLED STUDY; CRYSTALLOID; DIASTOLE; DRUG DOSE COMPARISON; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT RECIPIENT; HEART FUNCTION; HEART PROTECTION; HEART TRANSPLANTATION; HYPOTHERMIA; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; STATISTICAL SIGNIFICANCE; SYSTOLE; WESTERN BLOTTING;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; BLOOD PRESSURE; DECANOIC ACIDS; DIASTOLE; HEART; HEART TRANSPLANTATION; HYDROXY ACIDS; ISCHEMIC PRECONDITIONING; MALE; MODELS, ANIMAL; PIPERAZINES; PURINES; RATS; RATS, WISTAR; SULFONES; SYSTOLE; TRANSPLANTATION, HETEROTOPIC; TROPONIN I; VASODILATOR AGENTS;

EID: 76649121211     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181c42b22     Document Type: Article

References (33)

1. Banner NR, Thomas HL, Curnow E, et al. The importance of cold and warm cardiac ischemia for survival after heart transplantation. Transplantation 2008; 86: 542.
2. Taylor DO, Edwards LB, Aurora P, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fifth official adult heart transplant report-2008. J Heart Lung Transplant 2008; 27: 943.
3. Zaugg M, Lucchinetti E, Spahn DR, et al. Volatile anesthetics mimic cardiac preconditioning by priming the activation of mitochondrial K(ATP) channels via multiple signaling pathways. Anesthesiology 2002; 97:4.
4. Wakeno-Takahashi M, Otani H, Nakao S, et al. Adenosine and a nitric oxide donor enhances cardioprotection by preconditioning with isoflurane through mitochondrial adenosine triphosphate-sensitive K+ channel-dependent and-independent mechanisms. Anesthesiology 2004; 100: 515.
5. Das A, Ockaili R, Salloum F, et al. Protein kinase C plays an essential role in sildenafil-induced cardioprotection in rabbits. Am J Physiol Heart Circ Physiol 2004; 286: H1455.
6. Ockaili R, Salloum F, Hawkins J, et al. Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits. Am J Physiol Heart Circ Physiol 2002; 283: H1263.
7. du Toit EF, Rossouw E, Salie R, et al. Effect of sildenafil on reperfusion function, infarct size, and cyclic nucleotide levels in the isolated rat heart model. Cardiovasc Drugs Ther 2005; 19: 23.
8. Das S, Maulik N, Das DK, et al. Cardioprotection with sildenafil, a selective inhibitor of cyclic 3 ', 5 '-monophosphate-specific phosphodiesterase 5. Drugs Exp Clin Res 2002; 28: 213.
9. Salloum FN, Takenoshita Y, Ockaili RA, et al. Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits. JMol Cell Cardiol 2007; 42: 453.
10. Das A, Xi L, Kukreja RC. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. J Biol Chem 2005; 280: 12944.
11. Korom S, Hillinger S, Cardell M, et al. Sildenafil extends survival and graft function in a large animal lung transplantation model. EurJ Car-diothorac Surg 2006; 29: 288.
12. Pizanis N, Milekhin V, Tsagakis K, et al. PDE-5 inhibitor donor intravenous preconditioning is superior to supplementation in standard preservation solution in experimental lung transplantation. EurJ Car-diothorac Surg 2007; 32: 42.
13. Kulkarni A, Singh TP, Sarnaik A, et al. Sildenafil for pulmonary hypertension after heart transplantation. J Heart Lung Transplant 2004; 23:1441.
14. Alaeddini J, Uber PA, ParkMH, et al. Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure. AmJ Cardiol 2004; 94: 1475.
15. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
16. Loganathan S, Radovits T, Hirschberg K, et al. Effects of selective phosphodiesterase-5-inhibition on myocardial contractility and reperfusion injury after heart transplantation. Transplantation 2008; 86: 1414.
17. Russo MJ, Chen JM, Sorabella RA, et al. The effect of ischemic time on survival after heart transplantation varies by donor age: An analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg 2007; 133: 554.
18. Galinanes M, Hearse DJ. Metabolic, functional, and histologic characterization of the heterotopically transplanted rat heart when used as a model for the study of long-term recovery from global ischemia. J Heart Lung Transplant 1991; 10 (1 Part 1): 79.
19. 2 generation by rat heart mitochondria. Mol Cell Biochem 2008;309:77.
20. + exchange inhibition. Eur J Cardiothorac Surg 2006; 29(suppl 1): S107.
21. + exchanger blockade and protection against myocardial infarction. Hypertension 2007; 49: 1095.
22. Costa AD, Garlid KD, West IC, et al. Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. CircRes 2005; 97: 329.
23. Krieg T, Philipp S, Cui L, et al. Peptide blockers of PKG inhibit ROS generation by acetylcholine and bradykinin in cardiomyocytes but fail to block protection in the whole heart. Am J Physiol Heart Circ Physiol 2005; 288: H1976.
24. Das A, Xi L, Kukreja RC. Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta. JBiol Chem 2008; 283: 29572.
25. Das A, Salloum FN, Xi L, et al. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice. AmJ Physiol Heart CircPhysiol 2009; 296: H1236.
26. Uecker M, Da Silva R, Grampp T, et al. Translocation of protein kinase C isoforms to subcellular targets in ischemic and anesthetic preconditioning. Anesthesiology 2003; 99: 138.
27. Jiang MT, Ljubkovic M, Nakae Y, et al. Characterization of human cardiac mitochondrial ATP-sensitive potassium channel and its regulation by phorbol ester in vitro. Am J Physiol Heart Circ Physiol 2006; 290: H1770.
28. + channels in sildenafil-induced late car-dioprotection. JMol Cell Cardiol2008; 44: 105.
29. Drose S, Brandt U, Hanley PJ. K+-independent actions of diazoxide question the role of inner membrane KATP channels in mitochondrial cytoprotective signaling. J Biol Chem 2006; 281: 23733.
30. Pain T, Yang XM, Critz SD, et al. Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res 2000; 87: 460.
31. PasdoisP, BeauvoitB, Tariosse L, et al. Effect of diazoxide on flavopro-tein oxidation and reactive oxygen species generation during ischemia-reperfusion: A study on Langendorff-perfused rat hearts using optic fibers. Am J Physiol Heart Circ Physiol 2008; 294: H2088.
32. Finegan BA, Gandhi M, Cohen MR, et al. Isoflurane alters energy substrate metabolism to preserve mechanical function in isolated rat hearts following prolonged no-flow hypothermic storage. Anesthesiology 2003; 98: 379.
33. Galinanes M, Hearse DJ. Species differences in susceptibility to ischemic injury and responsiveness to myocardial protection. Cardio-science 1990; 1: 127.